Next Article in Journal
Health Technology Assessment of Vaccines in Italy: History and Review of Applications
Next Article in Special Issue
Symptomatology and IgG Levels before and after SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals
Previous Article in Journal
A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
Previous Article in Special Issue
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
 
 
Review

Article Versions Notes

Vaccines 2024, 12(10), 1089; https://doi.org/10.3390/vaccines12101089
Action Date Notes Link
article xml file uploaded 24 September 2024 13:34 CEST Original file -
article xml uploaded. 24 September 2024 13:34 CEST Update https://www.mdpi.com/2076-393X/12/10/1089/xml
article pdf uploaded. 24 September 2024 13:34 CEST Version of Record https://www.mdpi.com/2076-393X/12/10/1089/pdf
article html file updated 24 September 2024 13:36 CEST Original file https://www.mdpi.com/2076-393X/12/10/1089/html
Back to TopTop